Calumet Inc (CLMT) does not present a strong buy opportunity at this time for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators are neutral, insider selling has significantly increased, and the company's financial performance shows declining profitability. While analysts have raised price targets and maintain a generally positive outlook, the lack of strong trading signals and mixed catalysts suggest holding off on purchasing the stock for now.
The MACD is below zero and negatively contracting, indicating a lack of bullish momentum. RSI is neutral at 52.952, and moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 32.76, with resistance at 34.105 and support at 31.416.

Analysts have raised price targets significantly, with H.C. Wainwright setting a target of $60 due to expectations of improving pricing and demand for renewable fuels. The company is positioned as a low-cost renewables producer, which could benefit from sustained energy market disruptions.
Insider selling has increased by 261.65% over the last month, which may indicate a lack of confidence from those closest to the company. Financial performance shows a decline in net income, EPS, and gross margin. Additionally, hedge funds are neutral, and there is no recent congress trading data to suggest influential support.
In Q4 2025, revenue increased by 9.38% YoY to $1.0386 billion. However, net income dropped by -8.35% YoY to -$37.3 million, EPS fell by -8.51% YoY to -$0.43, and gross margin declined significantly by -103.30% YoY to -0.29. These figures highlight declining profitability despite revenue growth.
Analysts maintain a generally positive outlook, with multiple price target increases. H.C. Wainwright raised the target to $60, Goldman Sachs to $34, and BofA to $33, all with Buy ratings. However, TD Cowen remains cautious with a Hold rating and a $25 target, citing uncertainty around certain business segments.